$RDGL .006 this #biotech has limitless POTENTIAL I would

New Post Public Reply Private Reply Replies (0) Message Board
TKE_PENNY_STOCKS
609
$RDGL .006 this #biotech has limitless POTENTIAL I would notbe surprised to see it break $5 sometime in its future and I'm being very honest. An investor recently purchased over 5 million shares! Do your due diligence, the more you read the more you will understand. BIG MONEY traders LOADING HEAVY. VOLUME has gone up over 20x. Don't sleep.
https://www.slideshare.net/…/advanced-medic...e-corp-…

$RDGL TOP 5 MUST READS! All from Page 1 of the FORM S-1 filing with the Securities and Exchange Commission on February 8 , 2018, link included right below this.....

https://backend.otcmarkets.com/…/sec-…/12...ntent/html

1) Radiogel approved to treat feline sarcomas and canine soft tissue sarcomas, which is the most common type of cancer in animals"

2) Battelle has granted us an exclusive license to patents covering the manufacturing, processing and applications of RadioGel™ (the “ Battelle License ”). Other intellectual property protection for RadioGel™ includes proprietary production processes and trademark protection in 17 countries. We plan to continue efforts to develop new refinements on the production process, and the product and application hardware, as a basis for future patents."

3) A contract was signed with University of Missouri to treat canine sarcomas and equine sarcoids starting early in 2019. The safety review at UC Davis is almost completed. They will be treating prostate and liver cancer in dogs in 2019."

4) These animal therapies will focus on creating labels that describe the procedures in detail as a guide to future veterinarians. The labels will be voluntarily submitted to the FDA for review. They will then be used as data for future FDA applications in the medical sector and as key intellectual property for licensing to private veterinary clinics.

5)We anticipate that future profit will be derived from direct sales of RadioGel™ and related services, and from licensing to private medical and veterinary clinics in the U.S. and internationally.

Business Summary

Heres the full Page 1 excerpts: As filed with the Securities and Exchange Commission on February 8 , 2018

https://backend.otcmarkets.com/…/sec-…/12...ntent/html

"Our IsoPet Solutions division was established in May 2016 to focus on the veterinary oncology market, namely engagement of university veterinarian hospitals to develop the detailed therapy procedures to treat animal tumors and ultimately use of the technology in private clinics. In January 2018, we received notification from the FDA that the Center for Veterinary Medicine Product Classification Group ruled that RadioGel™ is classified as a device for animal therapy of feline sarcomas and canine soft tissue sarcomas, which is the most common type of cancer in animals. In addition, the FDA also reviewed and approved our label, which is a requirement for any device used in animals.

"RadioGel™ incorporates patented technology developed for Battelle Memorial Institute (“ Battelle ”) at Pacific Northwest National Laboratory, a leading research institute for government and commercial customers. Battelle has granted us an exclusive license to patents covering the manufacturing, processing and applications of RadioGel™ (the “ Battelle License ”). Other intellectual property protection for RadioGel™ includes proprietary production processes and trademark protection in 17 countries. We plan to continue efforts to develop new refinements on the production process, and the product and application hardware, as a basis for future patents."

"We have worked with four different university veterinarian hospitals on RadioGel™ testing and therapy. Colorado State University demonstrated the procedures and the CT and PET-CT imaging of RadioGel. Washington State University treated four cats for feline sarcoma. They concluded that the product was safe and effective in killing cancer cells. A contract was signed with University of Missouri to treat canine sarcomas and equine sarcoids starting early in 2019. The safety review at UC Davis is almost completed. They will be treating prostate and liver cancer in dogs in 2019."

These animal therapies will focus on creating labels that describe the procedures in detail as a guide to future veterinarians. The labels will be voluntarily submitted to the FDA for review. They will then be used as data for future FDA applications in the medical sector and as key intellectual property for licensing to private veterinary clinics.

https://www.slideshare.net/RedChip/advanced-m...L/376/RDGL
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 199

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 244

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Kayla Harrison Dominates UFC 334, Earns Big Win

Updated Category News Views 59

Kicking off UFC 334 with a bang, Kayla Harrison didn't just step into the Octagon—she bulldozed her way through Amanda Nunes to retain her Women's Bantamweight Championship. This showdown didn't just electrify New York's Madison Square Garden, it shook the entire MMA landscape. Harrison, the face of Monster Energy's athlete roster, wasn't content with just defending her...

Continue Reading
Hanwha Power Seals Second FSRU Conversion Deal

Updated Category News Views 47

Riding the FSRU Wave with Hanwha Power Alright, we've got Hanwha Power step-dancing onto the LNG stage with its second splash into the FSRU (Floating Storage and Regasification Unit) conversion gig. Partnering up with Energos Infrastructure, these guys are making serious waves in the energy market by transforming what's pretty much a regular ship into a floating gas...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 234

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
Local Voices to Shape Mekong's Story in New Alliance

Updated Category News Views 129

Unpacking the New Storytelling Strategy Right off the bat, let's make it clear—this isn't just another run-of-the-mill environmental project announcement. When the National Geographic Society teams up with ThaiBev to empower Southeast Asian storytellers, they're not just waving around the usual conservation banner. Instead, they're betting on local voices to lead the...

Continue Reading
FFR's Michigan Milestone and Major Robotics Update

Updated Category News Views 63

Nobody's going to argue that breaking into new territories isn't a gamble, but sometimes you just need to roll the dice. FF EAI Robotics Ecosystem Inc. (NASDAQ: FFR) is banking on their move with Aegis Ultra robots, making an academic splash at Central Michigan University. This isn't just about ticking off another state; it's about stacking the deck with new...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 266

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 324

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 416

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading

Top 5 Most Recently Viewed Articles

Celebrating 50 Years: Mobil 1™ and Autodromo Partner Up

Updated Category News Views 237

Mobil 1™ Celebrates Milestone with Unique Autodromo Collaboration In a remarkable celebration of its 50-year anniversary, Mobil 1™, a pioneer in synthetic motor oil, has teamed up with Autodromo, renowned for its driving-inspired watches. This collaboration introduces the Mobil 1 Edition Monoposto, a limited-edition timepiece, showcasing their shared commitment to...

Continue Reading
diaMentis Introduces Innovative Breakthrough in Mental Health Diagnosis

Updated Category News Views 256

Advancements in Mental Health Diagnosis diaMentis, known for its forward-thinking diagnostic support technology, is making waves in the mental health sector by revealing groundbreaking results that enhance the diagnosis of mental illnesses. These findings not only signify a major breakthrough, but also represent a turning point for the company, enhancing its reputation in...

Continue Reading
CleanSpark's Impressive Growth: Achieving 30 EH/s in Hashrate

Updated Category News Views 77

CleanSpark's Breakthrough in Hashrate Efficiency CleanSpark Inc. (NASDAQ: CLSK), renowned as America's leading bitcoin miner, recently reached an operational hashrate of 30 EH/s (exahashes per second). This significant milestone reflects the company's remarkable growth and innovation in the competitive bitcoin mining industry. Transformative Growth through Strategic...

Continue Reading
Baidu's Bold Move: Aiming to Compete in Global Robotaxi Market

Updated Category News Views 108

Baidu's Ambitious Expansion Plans in Robotaxi Services Baidu Inc. is reportedly considering an exciting venture to extend its renowned robotaxi service, Apollo Go, into international markets. This bold decision follows a significant transition within the company as its CFO, Rong Luo, assumes a new role. Such developments signal Baidu's commitment to unlocking new avenues...

Continue Reading
Airship AI Secures Major Federal Contracts Amid Growing Demand

Updated Category News Views 198

Airship AI Achieves Significant Federal Contracts REDMOND, Wash. — Airship AI Holdings, Inc. (NASDAQ: AISP) is celebrating a remarkable accomplishment in the realm of public safety and security. The company has recently secured 16 individual contracts from various federal law enforcement agencies, highlighting the ongoing relevance and necessity of AI technologies in...

Continue Reading